Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.
Identifieur interne : 002916 ( Ncbi/Merge ); précédent : 002915; suivant : 002917Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.
Auteurs : Z. Gu ; E J Rogers ; P S LovettSource :
- Journal of bacteriology [ 0021-9193 ] ; 1993.
Descripteurs français
- KwdFr :
- ARN bactérien, Bacillus subtilis (enzymologie), Bacillus subtilis (génétique), Chloramphenicol O-acetyltransferase (génétique), Chloramphenicol O-acetyltransferase (métabolisme), Chloramphénicol (pharmacologie), Cinétique, Données de séquences moléculaires, Induction enzymatique, Lincomycine (pharmacologie), Peptidyl transferases (), Peptidyl transferases (antagonistes et inhibiteurs), Ribosomes (métabolisme), Résistance microbienne aux médicaments (génétique), Signaux de triage des protéines (génétique), Signaux de triage des protéines (métabolisme), Séquence d'acides aminés, Séquence nucléotidique, Érythromycine (pharmacologie).
- MESH :
- antagonistes et inhibiteurs : Peptidyl transferases.
- enzymologie : Bacillus subtilis.
- génétique : Bacillus subtilis, Chloramphenicol O-acetyltransferase, Résistance microbienne aux médicaments, Signaux de triage des protéines.
- métabolisme : Chloramphenicol O-acetyltransferase, Ribosomes, Signaux de triage des protéines.
- pharmacologie : Chloramphénicol, Lincomycine, Érythromycine.
- ARN bactérien, Cinétique, Données de séquences moléculaires, Induction enzymatique, Peptidyl transferases, Séquence d'acides aminés, Séquence nucléotidique.
English descriptors
- KwdEn :
- Amino Acid Sequence, Bacillus subtilis (enzymology), Bacillus subtilis (genetics), Base Sequence, Chloramphenicol (pharmacology), Chloramphenicol O-Acetyltransferase (genetics), Chloramphenicol O-Acetyltransferase (metabolism), Drug Resistance, Microbial (genetics), Enzyme Induction, Erythromycin (pharmacology), Kinetics, Lincomycin (pharmacology), Molecular Sequence Data, Peptidyl Transferases (antagonists & inhibitors), Peptidyl Transferases (drug effects), Protein Sorting Signals (genetics), Protein Sorting Signals (metabolism), RNA, Bacterial, Ribosomes (metabolism).
- MESH :
- chemical , antagonists & inhibitors : Peptidyl Transferases.
- chemical , drug effects : Peptidyl Transferases.
- chemical , genetics : Chloramphenicol O-Acetyltransferase, Protein Sorting Signals.
- chemical , metabolism : Chloramphenicol O-Acetyltransferase, Protein Sorting Signals.
- chemical , pharmacology : Chloramphenicol, Erythromycin, Lincomycin.
- enzymology : Bacillus subtilis.
- genetics : Bacillus subtilis, Drug Resistance, Microbial.
- metabolism : Ribosomes.
- Amino Acid Sequence, Base Sequence, Enzyme Induction, Kinetics, Molecular Sequence Data, RNA, Bacterial.
Abstract
The site of ribosome stalling in the leader of cat transcripts is critical to induction of downstream translation. Site-specific stalling requires translation of the first five leader codons and the presence of chloramphenicol, a sequence-independent inhibitor of ribosome elongation. We demonstrate in this report that a synthetic peptide (the 5-mer) corresponding to the N-terminal five codons of the cat-86 leader inhibits peptidyl transferase in vitro. The N-terminal 2-, 3-, and 4-mers and the reverse 5-mer (reverse amino acid sequence of the 5-mer) are virtually without effect on peptidyl transferase. A missense mutation in the cat-86 leader that abolishes induction in vivo corresponds to an amino acid replacement in the 5-mer that completely relieves peptidyl transferase inhibition. In contrast, a missense mutation that does not interfere with in vivo induction corresponds to an amino acid replacement in the 5-mer that does not significantly alter peptidyl transferase inhibition. Our results suggest that peptidyl transferase inhibition by the nascent cat-86 5-mer peptide may be the primary determinant of the site of ribosome stalling in the leader. A model based on this concept can explain the site specificity of ribosome stalling as well as the response of induction to very low levels of the antibiotic inducer.
DOI: 10.1128/jb.175.17.5309-5313.1993
PubMed: 7690023
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002912
- to stream PubMed, to step Curation: 002912
- to stream PubMed, to step Checkpoint: 002770
Links to Exploration step
pubmed:7690023Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.</title>
<author><name sortKey="Gu, Z" sort="Gu, Z" uniqKey="Gu Z" first="Z" last="Gu">Z. Gu</name>
<affiliation><nlm:affiliation>Department of Biological Sciences, University of Maryland Baltimore County, Catonsville 21228.</nlm:affiliation>
<wicri:noCountry code="subField">Catonsville 21228</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rogers, E J" sort="Rogers, E J" uniqKey="Rogers E" first="E J" last="Rogers">E J Rogers</name>
</author>
<author><name sortKey="Lovett, P S" sort="Lovett, P S" uniqKey="Lovett P" first="P S" last="Lovett">P S Lovett</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1993">1993</date>
<idno type="RBID">pubmed:7690023</idno>
<idno type="pmid">7690023</idno>
<idno type="doi">10.1128/jb.175.17.5309-5313.1993</idno>
<idno type="wicri:Area/PubMed/Corpus">002912</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002912</idno>
<idno type="wicri:Area/PubMed/Curation">002912</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002912</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002770</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002770</idno>
<idno type="wicri:Area/Ncbi/Merge">002916</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.</title>
<author><name sortKey="Gu, Z" sort="Gu, Z" uniqKey="Gu Z" first="Z" last="Gu">Z. Gu</name>
<affiliation><nlm:affiliation>Department of Biological Sciences, University of Maryland Baltimore County, Catonsville 21228.</nlm:affiliation>
<wicri:noCountry code="subField">Catonsville 21228</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rogers, E J" sort="Rogers, E J" uniqKey="Rogers E" first="E J" last="Rogers">E J Rogers</name>
</author>
<author><name sortKey="Lovett, P S" sort="Lovett, P S" uniqKey="Lovett P" first="P S" last="Lovett">P S Lovett</name>
</author>
</analytic>
<series><title level="j">Journal of bacteriology</title>
<idno type="ISSN">0021-9193</idno>
<imprint><date when="1993" type="published">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Bacillus subtilis (enzymology)</term>
<term>Bacillus subtilis (genetics)</term>
<term>Base Sequence</term>
<term>Chloramphenicol (pharmacology)</term>
<term>Chloramphenicol O-Acetyltransferase (genetics)</term>
<term>Chloramphenicol O-Acetyltransferase (metabolism)</term>
<term>Drug Resistance, Microbial (genetics)</term>
<term>Enzyme Induction</term>
<term>Erythromycin (pharmacology)</term>
<term>Kinetics</term>
<term>Lincomycin (pharmacology)</term>
<term>Molecular Sequence Data</term>
<term>Peptidyl Transferases (antagonists & inhibitors)</term>
<term>Peptidyl Transferases (drug effects)</term>
<term>Protein Sorting Signals (genetics)</term>
<term>Protein Sorting Signals (metabolism)</term>
<term>RNA, Bacterial</term>
<term>Ribosomes (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN bactérien</term>
<term>Bacillus subtilis (enzymologie)</term>
<term>Bacillus subtilis (génétique)</term>
<term>Chloramphenicol O-acetyltransferase (génétique)</term>
<term>Chloramphenicol O-acetyltransferase (métabolisme)</term>
<term>Chloramphénicol (pharmacologie)</term>
<term>Cinétique</term>
<term>Données de séquences moléculaires</term>
<term>Induction enzymatique</term>
<term>Lincomycine (pharmacologie)</term>
<term>Peptidyl transferases ()</term>
<term>Peptidyl transferases (antagonistes et inhibiteurs)</term>
<term>Ribosomes (métabolisme)</term>
<term>Résistance microbienne aux médicaments (génétique)</term>
<term>Signaux de triage des protéines (génétique)</term>
<term>Signaux de triage des protéines (métabolisme)</term>
<term>Séquence d'acides aminés</term>
<term>Séquence nucléotidique</term>
<term>Érythromycine (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Peptidyl Transferases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Peptidyl Transferases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Chloramphenicol O-Acetyltransferase</term>
<term>Protein Sorting Signals</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Chloramphenicol O-Acetyltransferase</term>
<term>Protein Sorting Signals</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Chloramphenicol</term>
<term>Erythromycin</term>
<term>Lincomycin</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Peptidyl transferases</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Bacillus subtilis</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Bacillus subtilis</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Bacillus subtilis</term>
<term>Drug Resistance, Microbial</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Bacillus subtilis</term>
<term>Chloramphenicol O-acetyltransferase</term>
<term>Résistance microbienne aux médicaments</term>
<term>Signaux de triage des protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Ribosomes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Chloramphenicol O-acetyltransferase</term>
<term>Ribosomes</term>
<term>Signaux de triage des protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Chloramphénicol</term>
<term>Lincomycine</term>
<term>Érythromycine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Base Sequence</term>
<term>Enzyme Induction</term>
<term>Kinetics</term>
<term>Molecular Sequence Data</term>
<term>RNA, Bacterial</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>ARN bactérien</term>
<term>Cinétique</term>
<term>Données de séquences moléculaires</term>
<term>Induction enzymatique</term>
<term>Peptidyl transferases</term>
<term>Séquence d'acides aminés</term>
<term>Séquence nucléotidique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The site of ribosome stalling in the leader of cat transcripts is critical to induction of downstream translation. Site-specific stalling requires translation of the first five leader codons and the presence of chloramphenicol, a sequence-independent inhibitor of ribosome elongation. We demonstrate in this report that a synthetic peptide (the 5-mer) corresponding to the N-terminal five codons of the cat-86 leader inhibits peptidyl transferase in vitro. The N-terminal 2-, 3-, and 4-mers and the reverse 5-mer (reverse amino acid sequence of the 5-mer) are virtually without effect on peptidyl transferase. A missense mutation in the cat-86 leader that abolishes induction in vivo corresponds to an amino acid replacement in the 5-mer that completely relieves peptidyl transferase inhibition. In contrast, a missense mutation that does not interfere with in vivo induction corresponds to an amino acid replacement in the 5-mer that does not significantly alter peptidyl transferase inhibition. Our results suggest that peptidyl transferase inhibition by the nascent cat-86 5-mer peptide may be the primary determinant of the site of ribosome stalling in the leader. A model based on this concept can explain the site specificity of ribosome stalling as well as the response of induction to very low levels of the antibiotic inducer.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7690023</PMID>
<DateCompleted><Year>1993</Year>
<Month>10</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9193</ISSN>
<JournalIssue CitedMedium="Print"><Volume>175</Volume>
<Issue>17</Issue>
<PubDate><Year>1993</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of bacteriology</Title>
<ISOAbbreviation>J. Bacteriol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene.</ArticleTitle>
<Pagination><MedlinePgn>5309-13</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The site of ribosome stalling in the leader of cat transcripts is critical to induction of downstream translation. Site-specific stalling requires translation of the first five leader codons and the presence of chloramphenicol, a sequence-independent inhibitor of ribosome elongation. We demonstrate in this report that a synthetic peptide (the 5-mer) corresponding to the N-terminal five codons of the cat-86 leader inhibits peptidyl transferase in vitro. The N-terminal 2-, 3-, and 4-mers and the reverse 5-mer (reverse amino acid sequence of the 5-mer) are virtually without effect on peptidyl transferase. A missense mutation in the cat-86 leader that abolishes induction in vivo corresponds to an amino acid replacement in the 5-mer that completely relieves peptidyl transferase inhibition. In contrast, a missense mutation that does not interfere with in vivo induction corresponds to an amino acid replacement in the 5-mer that does not significantly alter peptidyl transferase inhibition. Our results suggest that peptidyl transferase inhibition by the nascent cat-86 5-mer peptide may be the primary determinant of the site of ribosome stalling in the leader. A model based on this concept can explain the site specificity of ribosome stalling as well as the response of induction to very low levels of the antibiotic inducer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
<AffiliationInfo><Affiliation>Department of Biological Sciences, University of Maryland Baltimore County, Catonsville 21228.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rogers</LastName>
<ForeName>E J</ForeName>
<Initials>EJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lovett</LastName>
<ForeName>P S</ForeName>
<Initials>PS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>GM-42925</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Bacteriol</MedlineTA>
<NlmUniqueID>2985120R</NlmUniqueID>
<ISSNLinking>0021-9193</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D021382">Protein Sorting Signals</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012329">RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>63937KV33D</RegistryNumber>
<NameOfSubstance UI="D004917">Erythromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>66974FR9Q1</RegistryNumber>
<NameOfSubstance UI="D002701">Chloramphenicol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>BOD072YW0F</RegistryNumber>
<NameOfSubstance UI="D008034">Lincomycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.1.28</RegistryNumber>
<NameOfSubstance UI="D015500">Chloramphenicol O-Acetyltransferase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.3.2.12</RegistryNumber>
<NameOfSubstance UI="D010458">Peptidyl Transferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<GeneSymbolList><GeneSymbol>cat</GeneSymbol>
</GeneSymbolList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001412" MajorTopicYN="N">Bacillus subtilis</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002701" MajorTopicYN="N">Chloramphenicol</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015500" MajorTopicYN="N">Chloramphenicol O-Acetyltransferase</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004917" MajorTopicYN="N">Erythromycin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008034" MajorTopicYN="N">Lincomycin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010458" MajorTopicYN="N">Peptidyl Transferases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021382" MajorTopicYN="N">Protein Sorting Signals</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012329" MajorTopicYN="N">RNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012270" MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year>
<Month>9</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1993</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1993</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7690023</ArticleId>
<ArticleId IdType="pmc">PMC206583</ArticleId>
<ArticleId IdType="doi">10.1128/jb.175.17.5309-5313.1993</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Mol Biol. 1965 Nov;14(1):63-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5327658</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Microbiol. 1993 Jun;8(6):1063-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7689687</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1967 Aug 28;28(1):161-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6051749</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1982 May;150(2):815-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6950931</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Genet. 1982;16:113-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6186194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gene. 1983 Oct;24(2-3):171-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6416927</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1984 Jun;158(3):784-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6327638</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CRC Crit Rev Biochem. 1984;16(2):103-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6203682</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 1985 Jan 1;179(1):101-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3855295</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1985 Feb;4(2):533-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4018035</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EMBO J. 1985 Sep;4(9):2295-300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3865770</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1986 Sep;167(3):842-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3462183</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1987 Sep;169(9):4235-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3114238</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1988 May;85(9):3057-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3129723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Gen Genet. 1988 Sep;214(1):108-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2465483</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1989 Mar 5;206(1):69-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2467989</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1989 Aug;86(15):5763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2762294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1990 Jan;172(1):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2403536</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1990 Jan;172(1):110-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2294082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 1990 Jul 13;62(1):117-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2163764</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Bacteriol. 1990 Nov;172(11):6282-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2121710</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1992 Jun 5;256(5062):1416-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1604315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Microbiol. 1992 Oct;6(19):2769-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1279359</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1967 Apr 28;25(2):347-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6034103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Gu, Z" sort="Gu, Z" uniqKey="Gu Z" first="Z" last="Gu">Z. Gu</name>
<name sortKey="Lovett, P S" sort="Lovett, P S" uniqKey="Lovett P" first="P S" last="Lovett">P S Lovett</name>
<name sortKey="Rogers, E J" sort="Rogers, E J" uniqKey="Rogers E" first="E J" last="Rogers">E J Rogers</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002916 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002916 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:7690023 |texte= Peptidyl transferase inhibition by the nascent leader peptide of an inducible cat gene. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:7690023" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |